Markets › United States › NAS › AGMB

AgomAb Therapeutics NV

NAS:AGMBHealthcarenasdaq_composite

$8.97+8.99%LiveIn session · ≈ AED 32.94 · Market cap $444.44M · Next earnings Wed 3 Mar

Ratio	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	—	—	—	−45.9%	−45.9%	+0.0 pts
Return on assets	—	—	—	−39.1%	−39.1%	+0.0 pts
Return on capital employed	—	—	—	−43.9%	—	—
Debt / equity	—	—	—	0.0×	0.0×	+0.0%
Debt / assets	—	—	—	0.8%	—	—
Interest coverage	−503.0×	−1,006.1×	−716.7×	−894.4×	—	—
Current ratio	—	—	—	6.5×	6.5×	+0.0%
Quick ratio	—	—	—	6.5×	—	—
Cash ratio	—	—	—	4.6×	4.6×	+0.0%
Asset turnover	—	—	—	0.0×	—	—
Receivables turnover	—	—	—	0.0×	—	—
Dividend payout	—	—	—	0.0%	—	—